New models of integrated health care management in nephrology;Nuevos modelos de gestión de asistencia integral en nefrología

Nefrologia

Volumn 33, Issue 3, 2013, Pages 301-307

  Ramos, Rosa ^a   Molina, Manolo ^b  

^a Fresenius Medical Care Spain   (Spain)

^b HOSPITAL UNIVERSITARIO SANTA LUCÍA   (Spain)

Author keywords

Chronic kidney disease; Integrated management; Reimbursement systems

Indexed keywords

ARTICLE; CHRONIC KIDNEY FAILURE; HUMAN; INTEGRATED HEALTH CARE SYSTEM; NEPHROLOGY; NONBIOLOGICAL MODEL; ORGANIZATION AND MANAGEMENT;

DELIVERY OF HEALTH CARE, INTEGRATED; HUMANS; MODELS, ORGANIZATIONAL; NEPHROLOGY; RENAL INSUFFICIENCY, CHRONIC;

EID: 84878082083     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2013.Feb.11638     Document Type: Article

References (38)

1. World Health Organization (WHO). Preventing Chronic Diseases: A Vital Investment: World Health Organization; 2005.
2. Anderson G. Chronic conditions: making the case for ongoing care. John Hopkins University; 2004.
3. Informe Abril. Comisión presidida por Abril Martorell F. JANO 1991;XLI(963):45-69.
4. Ochando Claramunt C. Reformas institucionales en la sanidad. Quaderns de Política Econòmica 2005;9:52-69.
5. IBM Global Business Services Healthcare. Healthcare 2015: Win-win or lose-lose? A portrait and a path to successful transformation; 2006.
6. US Renal Data System 2008 annual data report. Atlas of chronic kidney disease and end-stage renal disease in the United States. USRDS [online]; 2008.
7. Trivedi H. Cost implications of caring for chronic kidney disease: are interventions cost-effective?. Adv Chronic Kidney Dis 2010;17(3):265-70.
8. Arrieta J. Evaluación económica del tratamiento sustitutivo renal (hemodiálisis, diálisis peritoneal y trasplante) en España. Nefrologia 2010;1(Sup Ext 1):37-47.
9. De Francisco ALM. Sostenibilidad y equidad del tratamiento sustitutivo de la función renal en España. Nefrologia 2011;21(3):241-6.
10. Arrieta J, Rodríguez-Carmona A, Remón C, Pérez-Fontán M, Ortega F, Sánchez Tomero JA, et al. La diálisis peritoneal es la mejor alternativa coste-efectiva para la sostenibilidad del tratamiento con diálisis. Nefrologia 2011;31(5):505-13.
11. Lorenzo V, Perestelo L, Barroso M, Torres A, Nazco J. Evaluación económica de la hemodiálisis. Análisis de los componentes del coste basado en datos individuales. Nefrologia 2010;30(4):403-12.
12. Parra Moncasí E, Arenas MD, Alonso M, Martínez MF, Gámen Pardo A, Rebollo P, et al.; Grupo de Gestión de la Calidad de la Sociedad Española de Nefrología. Estudio multicéntrico de costes en hemodiálisis. Nefrologia 2011;31(3):299-307.
13. Roca Meroño S, De Alarcón Jiménez R, Jimeno Griñó C, Vaquero Parrizas E, Zarcos Pedrinaci E, Albadalejo Pérez M, et al. Coste farmacéutico en el paciente en hemodiálisis: Componentes principales y repercusión en el coste global. Nefrologia 2011;31 Supl 2:110.
14. Alcázar R, de Francisco ALM. Acción estratégica de la SEN frente a la enfermedad renal. Nefrologia 2006;26:1-4.
15. Blumenthal D, Buntin MB. Carve outs: definition, experience, and choice among candidate conditions. Am J Manag Care 1998;4 Suppl:SP45-57.
16. Ramirez SP. Chronic kidney disease prevention in Singapore. Clin J Am Soc Nephrol 2008;3(2):610-5.
17. Wingard RL, Pupim LB, Krishnan M, Shintani A, Ikizler TA, Hakim RM. Early intervention improves mortality and hospitalization rates in incident hemodialysis patients: RightStart program. Clin J Am Soc Nephrol 2007;2(6):1170-5.
18. Arbor Research Collaborative for Health. End Stage Renal Disease (ESRD) Disease Management Demonstration Evaluation Report: Findings from 2006-2008, the First Three Years of a Five Year Demonstration Prepared in collaboration with: The Lewin Group The National Opinion Research Center at the University of Chicago; 2010.
19. Bahr T, Burke M, Carey N, Coplon N, Luckinbill L, Mende C, et al. Integrated Renal Disease Management: A Provider's Response to Capitation and an Evolving Managed Care Marketplace. Dial Transplant 1997;26(4):206-16.
20. Martínez Castelao A, de Francisco ALM, Górriz JL, Alcázar R, Orte L; Grupo de Acción Estratégica de la S.E.N. Estrategias en salud renal: un proyecto de la Sociedad Española de Nefrología. Nefrologia 2009;29(3):185-92.
21. Epping-Jordan JE, Galea G, Tukuitonga C, Beaglehole R. Preventing chronic diseases: taking stepwise action. Lancet 2005;366(9497):1667-71.
22. Richards N, Harris K, Whitfield M, O'Donoghue D, Lewis R, Mansell M, et al. Primary care-based disease management of chronic kidney disease (CKD), based on estimated glomerular filtration rate (eGFR) reporting, improves patient outcomes. Nephrol Dial Transplant 2008;23(2):549-55.
23. Menzin J, Lines LM, Weiner DE, Neumann PJ, Nichols C, Rodriguez L, et al. A review of the costs and cost effectiveness of interventions in chronic kidney disease: implications for policy. Pharmacoeconomics 2011;29(10):839-61.
24. Palmer AJ, Valentine WJ, Chen R, Mehin N, Gabriel S, Bregman B, et al. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA. Nephrol Dial Transplant 2008;23(4):1216-23.
25. Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in US adults. JAMA 2003;290(23):3101-14.
26. Jaar BG, Khatib R, Plantinga L, Boulware LE, Powe NR. Principles of screening for chronic kidney disease. Clin J Am Soc Nephrol 2008;3(2):601-9.
27. Luxton G. Timing of referral of chronic kidney disease patients to nephrology services (adult). Nephrology (Carlton) 2010;15:S2-S11.
28. McLaughlin K, Manns B, Culleton B, Donaldson C, Taub K. An economic evaluation of early versus late referral of patients with progressive renal insufficiency. Am J Kidney Dis 2001;38(5):1122-8.
29. Waters HR, Hussey P. Pricing health services for purchasers-a review of methods and experiences. Health Policy 2004;70(2):175-84.
30. Aas IH. Incentives and financing methods. Health Policy 1995;34(3):205-20.
31. Telyukov A. Guide to prospective capitation with illustrations from Latin America. LAC-Health Sector Reform Initiative 2001;5.
32. Boletín Oficial de la Región de Murcia (BORM). 27 de febrero de; 2004.
33. E-Murcia: Servicios de salud. Anuncio de licitación. Estados miembros. Contrato de servicios 2010 [cited 235214-2010-ES]. Available at: http://ted.europa.eu/udl?uri=TED:NOTICE:235214-2010:TEXT:ES:HTML:[1-6].
34. NephroCare Quality Report 2010. Internal research& documentation.
35. Diario Oficial de la Unión Europea (DOUE). 7 agosto de; 2010.
36. Manns B, Tonelli M, Yilmaz S, Lee H, Laupland K, Klarenbach S, et al. Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysis. J Am Soc Nephrol 2005;16(1):201-9.
37. Gruss E, Portolés J, Tato A, Hernández T, López-Sánchez P, Velayos P, et al. Repercusiones clínicas y económicas del uso de catéteres tunelizados de hemodiálisis en un área sanitaria. Nefrologia 2009;29(2):123-9.
38. Sociedad Española de Nefrología. Guías de acceso vascular en hemodiálisis. Nefrologia 2005;25(Suppl 1):1-174